Search

Nixxi Announces the Imminent Publication of Its Research on Preterm Birth Biomarkers

Updated: Feb 5



Nixxi announces the upcoming publication of its research on preterm birth biomarkers, which will be published in the journal, Human Reproduction Open. The study demonstrates that a ratio of maternal steroid hormones, when tested as early as the late first trimester, accurately predicts a woman’s risk for spontaneous preterm birth prior to 32 weeks. The findings are important as early detection will allow clinicians to identify those women at risk for preterm delivery and implement behavioral and clinical interventions to mitigate the risk.

116 views

Recent Posts

See All

Nixxi Profiled on 360dx

We are pleased to share 360dx's profile of Nixxi. Our company is focused on creating clinical tools that address the most critical segment of premature births - those delivered prior to 32 weeks. Addi

© 2020 by Nixxi, Inc.

CONTACT

4340 E. Indian School Road, Suite 21-168

Phoenix, AZ 85018

info@nixxihealth.com

FOLLOW OUR PROGRESS